Allscripts' (MDRX) Fundamentals Strong Amid Stiff Competition
Zacks Investment Research | Feb 26, 2018 09:49PM ET
On Feb 26, we issued an updated research report on Allscripts Healthcare Solutions (NASDAQ:MDRX) . While the company’s strong fundamentals and acquisitions are major positives, rising operating expenses and integration risks remain major concerns. The stock carries a Zacks Rank #3 (Hold).
In the fourth quarter of 2017, the provider of information technology solutions to healthcare organizations witnessed strong financial results on strength in U.S. Core Solutions and Services, which was buoyed by the Sunrise electronic health record (EHR) platform and Allscripts Revenue Cycle Management Services. Notably, revenues in the quarter increased 27% on a year-over-year basis, while earnings per share saw 28.6% growth.
The company also has strong subsidiaries like Netsmart and CarePort, which are gaining from favorable market trends. Moreover, the company’s EHR agnostic tools, including dbMotion, EPSi, FollowMyHealth and 2bPrecise, are delivering strong results. These platforms have been gaining clients quite frequently. Furthermore, the company’s alliance with Optums has been strong.
Allscripts has also been benefitting from its acquisitions. Lately, the company signed an agreement to takeover Practice Fusion with a view to drive innovation. Moreover, the company recently expanded its strategic partnership with OptimizeRx Corp., a leading provider of digital health messaging.
Allscripts’ fourth quarter has seen active expansion of international business. Notably, the company introduced Maidstone in the U.K. It continues to expand its footprint in Australia on continued sale of the Sunrise-BOSSNet EHR platform to hospitals in Western Australia. Allscripts also initiated operations in Costa Rica with its flagship Sunrise platform.
On the flip side, in the fourth quarter, the company saw a 27% year-over-year rise in operating expenses. This was primarily due to the acquisition of EIS business of McKesson (NYSE:MCK) and a long sales cycle which involves decision-making at different managerial levels. This increases the company’s operating expenses and might result in cancellation of orders.
Allscripts’ continued dependence on acquisitions is also likely to pose substantial integration risks. To add to the woes, the company faces stiff competition from large players like Epic and Cerner in the Healthcare Information Technology space.
Allscripts has been underperforming the Zacks Investment Research
Get The News You Want
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.